SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001387131-22-012374
Filing Date
2022-12-13
Accepted
2022-12-13 16:50:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP autl-sc13g_120922.htm SC 13G 86946
2 ITEM 7 INFORMATION ex99-a.htm EX-99.A 3625
3 CERTIFICATE OF INCUMBENCY ex99-b.htm EX-99.B 7882
  Complete submission text file 0001387131-22-012374.txt   100079
Mailing Address P.O. BOX 23224 DOHA S3 QATAR
Business Address OOREDOO TOWER (BUILDING 14), AL DAFNA ST (STREET 801) DOHA S3 QATAR 974 441 4466
Qatar Investment Authority (Filed by) CIK: 0001441449 (see all company filings)

IRS No.: 000000000 | State of Incorp.: S3 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90550 | Film No.: 221460252
SIC: 2836 Biological Products, (No Diagnostic Substances)